Loading...
Market
What type of major restructuring or rebranding effort will Haleon announce by December 31, 2024?
2
Resolution / Starting Odds
Rebranding of Robitussin • 25%
Company-wide restructuring • 25%
Introduction of new product lines • 25%
No major changes • 25%
Company press releases and news reports
Story
Robitussin Maker Settles $4.5 Million Lawsuit Over 'Non-Drowsy' Claim
Jul 22, 2024, 08:49 PM
The maker of Robitussin, Haleon, has settled a consumer lawsuit that claimed its 'non-drowsy' cough and flu medicine causes drowsiness. As part of the settlement, Haleon agreed to pay $4.5 million and remove the 'non-drowsy' claim from its packaging and marketing. The settlement covers Robitussin purchasers from February 16, 2016, to the present.
View original story
Similar markets
Expansion into new markets • 25%
Introduction of new services • 25%
Layoffs or restructuring • 25%
Other • 25%
Acquisition • 25%
Divestiture • 25%
Spin-off • 25%
No major move • 25%
BWXT • 17%
Company 2 • 17%
Company 3 • 17%
Company 4 • 17%
Company 5 • 17%
Company 6 • 17%
New CEO • 25%
Spin-off of division • 25%
Major acquisition • 25%
No major changes • 25%
Major UI overhaul • 25%
Introduction of new features • 25%
Enhanced server infrastructure • 25%
No significant changes • 25%
Yes • 50%
No • 50%
Focus on non-U.S. investments • 25%
Reduce overall investments • 25%
Increase due diligence • 25%
No change • 25%
Yes, internal promotion • 25%
Yes, external hire • 25%
No change • 25%
Interim CEO appointed • 25%
Enhanced drone technology • 25%
AI software for military • 25%
Cyber defense systems • 25%
Other • 25%
Aerospace business separated • 25%
Aerospace business retained • 25%
Aerospace business sold • 25%
Other outcome • 25%